PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

City of Hope launches transformative national clinical trials model to accelerate cancer research

The innovative clinical trials network enables rapid and simultaneous trial openings across multiple locations, delivering top-tier cancer treatment to more patients nationwide

2025-09-09
(Press-News.org) LOS ANGELES — City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., launched an innovative national clinical trials model to expand access to emerging life-saving cancer treatments to more patients across the country. This model simplifies the opening of new trial locations and streamlines patient enrollment with the goal of accelerating the development of new cancer treatments and improving clinical care.  

As the first academic center with a national clinical trial network and a large and diverse patient population served through a national network of advanced cancer centers, City of Hope will offer unprecedented access to lifesaving care, novel therapies, and clinical decision-making expertise. Through the model, City of Hope operates a single centralized hub which has multiple research locations, enabling the organization to open a clinical trial across multiple states simultaneously with this centralized support. The operational efficiency of this national model reduces patient enrollment times, increases enrollment numbers and ensures patients across a wide geographic footprint have access to an extensive portfolio of leading-edge treatment options.  

“Our North Star is to offer all our patients, regardless of where they live, the opportunity to participate in clinical trials, which provide them with promising new treatment options long before they become the standard of care,” said Edward S. Kim, M.D., M.B.A., FACP, FASCO, vice physician-in-chief, City of Hope National Medical Center and system director, Clinical Trials.  “Whether a trial is sponsored by the NIH, by a pharmaceutical company or is studying an investigational medicine developed right here at City of Hope, the remarkable function of our new national model is the ability for a single institution to enroll patients in communities who don’t typically have access to these types of leading-edge trials. By building a single yet scalable model, we can now deliver on our vision to create access and care closer to those living with cancer.” 

Typically, clinical trial models face significant limitations, including where and when a clinical trial can open, the timely enrollment of patients, available resources and on-site expertise to support the trial. City of Hope’s new model was built to support a distributed, digitally connected network of clinical trial sites. The unique structure of the model means it can accommodate rapid expansion across the U.S. without needing to overhaul core systems. 

Another key differentiator of the model - it allows investigators to bring groundbreaking science to every City of Hope location, boosting the organization’s mission to make hope a reality for anyone touched by cancer or diabetes. 

Building on a Legacy
For over 100 years, City of Hope has served Los Angeles communities. Today, with 37 locations across the U.S., including premier cancer centers in Orange County, Phoenix, Chicago and Atlanta, millions of Americans of diverse backgrounds are now within 90 minutes of a City of Hope site. As a legacy organization known for its powerhouse research and clinical care — the expanded footprint called for a novel approach to its clinical trial framework. 

“Currently, the gap between those who can access therapeutic breakthroughs and those who can’t is widening and in many cases the issue is simply due to the zip code they reside in. Through innovation, City of Hope is removing barriers and bridging geographic divides, bringing our renowned clinical excellence closer to all patients,” said Marcel van den Brink, M.D., Ph.D., president, City of Hope Los Angeles and City of Hope National Medical Center and the Deana and Steve Campbell Chief Physician Executive Distinguished Chair. “This unique approach to clinical research, along with supportive care programs and personalized medicine, ensures every City of Hope patient can access the latest cancer advances.”

Early Success
In the first few months since launch, nine clinical trials across solid tumors and blood cancers are running at 12 City of Hope sites. With centralized support, patient enrollment is ahead of expectations and the studies are expected to reach their targets. 

“We are thrilled to collaborate with City of Hope to help pioneer this leading-edge model,” said John Pagel, M.D., Ph.D., Senior Vice President, Clinical Development, Global Head of Hematology, Eli Lilly and Company. “The new centralized model saves time and resources and has potential to lead to higher quality research and contribute to our ability to rapidly advance scientific innovation that can make a meaningful difference for patients.” 
 
A Phase 2 clinical trial of Lilly’s therapy for relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma is now open at eight City of Hope locations across the country.

Developing New Tools for Tomorrow’s Needs 
To deliver a scalable and unified system, regulatory, operational and digital frameworks were developed to accommodate new trial sites anywhere in the world. City of Hope experts are also developing AI and predictive tools to incorporate into the portal to help determine where certain patients reside and identify the best locations for each trial.

“City of Hope has built an all-in-one model that can not only keep up with the pace of our scientific research and clinical innovations, but also support our investigators and collaborators, and ultimately how we deliver care and most importantly, hope, to our patients, regardless of where they are,” Dr. Kim said.

To learn more about the clinical trials model contact: trialintake@coh.org. For details on participating in a clinical trial call: 855-970-2654.

# # #

About City of Hope
City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked among the nation’s top cancer centers by U.S. News & World Report at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training and innovation initiatives. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.
 

END



ELSE PRESS RELEASES FROM THIS DATE:

Inside an academic scandal: a story of fraud and betrayal

2025-09-09
In 2012 Max Bazerman, along with four coauthors, published an influential paper showing that “signing first”—that is, promising to tell the truth before filling out a form—produced greater honesty than signing afterward. In 2021, academic sleuths revealed that two of the experiments in the paper were fraudulent, triggering what would become one of the most significant academic frauds of the twenty-first century. In Inside an Academic Scandal, Bazerman tells the sobering story of how fraud in a published paper about inducing honesty upended countless academic careers, wreaked havoc in organizations ...

Innovative ultrasonic regeneration restores nano-phase change emulsions for low-temperature applications

2025-09-09
Phase change emulsions (NPCEs) have significant potential for energy storage and temperature regulation due to their high energy density and efficient heat transfer. However, in most conventional NPCEs, performance under low-temperature and shear conditions is often compromised, leading to droplet coalescence and instability. A team of scientists has developed a high-energy ultrasonic regeneration strategy that enables real-time restoration of NPCE performance without interrupting the operation cycle. Their work was published in the journal Industrial Chemistry & Materials on July 28. “We aim to develop a robust emulsion system that can withstand ...

Targeted snow monitoring at hotspots outperforms basin-wide surveys in predicting water supply

2025-09-09
CORVALLIS, Ore. – Measuring mountain snowpack at strategically selected hotspots consistently outperforms broader basin-wide mapping in predicting water supply in the western United States, a new study found. Researchers analyzed more than 20 years of snow estimates and streamflow data across 390 snow-fed basins in 11 western states to evaluate two potential strategies for expanded snow monitoring. This analysis revealed locations the researchers are calling hotspots — localized areas ...

Decades-old barrels of industrial waste still impacting ocean floor off Los Angeles

2025-09-09
In 2020, haunting images of corroded metal barrels in the deep ocean off Los Angeles leapt into the public consciousness. Initially linked to the toxic pesticide DDT, some barrels were encircled by ghostly halos in the sediment. It was unclear whether the barrels contained DDT waste, leaving the barrels’ contents and the eerie halos unexplained. Now, new research from UC San Diego's Scripps Institution of Oceanography reveals that the barrels with halos contained caustic alkaline ...

Finalists announced for the 2025 Blavatnik National Awards for Young Scientists

2025-09-09
September 9, 2025 – New York – The Blavatnik Family Foundation and The New York Academy of Sciences today announced the Finalists for the 2025 Blavatnik National Awards for Young Scientists. The Awards recognize scientific advances made by researchers in the United States across the following disciplines: Life Sciences, Chemical Sciences, and Physical Sciences & Engineering.   Subra Suresh, ScD, Former Director of the National Science Foundation and current President of the Global Learning Council in Switzerland, will announce the three 2025 ...

Alkali waste dumped in the Pacific Ocean created alkalophilic ecosystems

2025-09-09
Barrels filled with industrial waste that were dumped in the sea near Los Angeles more than 50 years ago are creating new microbial ecosystems adapted to highly alkaline conditions. It has been estimated that hundreds of thousands of barrels of waste were dumped off the coast of California in the mid 20th century. Previous investigations suggested that the barrels once contained dichlorodiphenyltrichloroethane (DDT)—an insecticide known for its broad toxicity that was banned for agricultural use in 1972. ...

Bacterial ink to restore coral reefs

2025-09-09
A living ink containing bacteria attracts coral larvae and could help rebuild reefs. Corals are struggling with water pollution, as well as warming and acidification caused by climate change. One way to support coral reef persistence is to encourage coral recruitment onto the reef. Coral larvae are free-swimming animals that eventually settle onto a surface and transform into a polyp with a hard, durable body. Certain bacteria secrete chemical cues that stimulate settlement and metamorphosis. Settled polyps may then reproduce asexually, expanding the size of the reef. Daniel Wangpraseurt and colleagues created a living material that encourages coral larvae to attach ...

AI-based satellite count of migrating wildebeest

2025-09-09
An AI-powered satellite counting effort conducted over two years concludes that less than 600,000 wildebeest migrate across the Serengeti-Mara ecosystem each year—half of previous estimates from manned aircraft surveys. Lions, hyenas, crocodiles, and tourism professionals all rely on the annual migration of wildebeest (Connochaetes taurinus) which transit through Kenya and Tanzania as the herds follow the seasonal growth of grass. Prior estimates of the migratory wildebeest population that make the trek each year were reached by extrapolating counts from aerial photos in the south of the ecosystem. Isla Duporge and colleagues ...

Bee-sting inspired microneedles from Chung-Ang University could revolutionize drug delivery

2025-09-09
Neurological diseases affect millions worldwide, and the need for long-term patient-friendly treatments has never been greater. While needle-based injections are the standard for most therapies, regular drug injections can often be painful and inconvenient. Microneedles—which are tiny, micron-sized needle systems— have emerged as a promising alternative to conventional needles and offer a pain free way to deliver medicines. However, most existing microneedles are rigid and can cause discomfort during prolonged use and therefore limits their adoption in long-term use. To overcome this, researchers from South Korea have designed a new microneedles system inspired by the ...

Pusan National University researchers reveal how uneven ocean warming is altering propagation of the Madden-Julian oscillation

2025-09-09
The Earth’s tropical regions drive some of the most powerful weather and climate variability globally. Among these, the Madden–Julian Oscillation (MJO) is a dominant intraseasonal climate signal, characterized by large clusters of clouds and rainfall that slowly move eastward across the warm tropical oceans. In doing so, the MJO shapes rainfall patterns, influences tropical cyclones, modulates monsoons, and even impacts weather far beyond the tropics. Understanding the factors that govern its ...

LAST 30 PRESS RELEASES:

Scientists create ChatGPT-like AI model for neuroscience to build one of the most detailed mouse brain maps to date

AI and omics unlock personalized drugs and RNA therapies for heart disease

2023 ocean heatwave ‘unprecedented but not unexpected’

Johns Hopkins researchers develop AI to predict risk of US car crashes

New drug combination offers hope for men with advanced prostate cancer

New discovery finds gene converts insulin-producing cells into blood-sugar boosters

Powerful and precise multi-color lasers now fit on a single chip

Scientists agree chemicals can affect behavior, but industry workers more reluctant about safety testing

DNA nanospring measures cellular motor power

Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research

Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates

Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches

Catching Alport syndrome through universal age-3 urine screening

Instructions help you remember something better than emotions or a good night’s sleep

Solar energy is now the world’s cheapest source of power, a Surrey study finds

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

[Press-News.org] City of Hope launches transformative national clinical trials model to accelerate cancer research
The innovative clinical trials network enables rapid and simultaneous trial openings across multiple locations, delivering top-tier cancer treatment to more patients nationwide